Non-alcoholic Fatty Liver Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patients met the diagnostic criteria of nonalcoholic fatty liver disease in the Guidelines for Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (2018 edition); 2. ALT > 42U/L, GGT > 50U/L; 3. Triglyceride > 1.71 umol/l, LDL > 3.1 umol/l or diagnosed as metabolic syndrome; 4. Fatty liver is indicated by ultrasound or MRI, or by liver biopsy; 5. Aged between 18 years and 50 years. 6. Patients who agree to participate in this clinical trial and voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Severe alcoholism (average daily intake of alcohol for women and women (> 20 g) and male (> 30 g); 2. Complicated with tumors, hypothyroidism, nephropathy, heart disease; 3. Complicated infection with viral hepatitis C or B, decompensated cirrhosis; 4. Active hepatitis caused by autoimmune hepatitis, hereditary liver disease and other causes; 5. NAFLD induced by drugs used in the past year, includes amiodarone, sodium valproate, tamoxifen, methotrexate, corticosteroids or antiretroviral agents; 6. ALT>500U/L or AST>500U/L; 7. Glycated hemoglobin > 8%. 8. Pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical indexes of serum;B ultrasound of Liver ;Liver elastography; | — |
Countries
China
Contacts
Jiangsu Provincial Hospital of Chinese Medicine (Affiliated Hospital of Nanjing University of Chinese Medicine)